Icade

Prepare for Healthcare's full deconsolidation

23/05/23 -"In anticipation of lower forward dividends resulting from the disposal of the Healthcare business through 2023-25 (c.40% of FFO in FY 22), we have reduced our dividend expectations for the out-years. ..."

PDF page sample
Pages
76
Language
English
Published on
23/05/23
Download
You may also be interested by these reports :
06/06/23
Gecina is a French Property company whose main asset is Offices. Next to this €14bn pocket, Residential weighs €4bn. Due to recent changes in ...
02/06/23
Acquires a property in Zurich West and consequently on higher rental income increases the adj. EBITDA guidance to CHF 290mn
31/05/23
Colonial’s FY 23 guidance is for stable FFO per share. This was in line with our initial expectation. In late 2022 and again in early 2023, the ...
30/05/23
Our target price has been revised downward under pressure from our reduced DCF and NAV derived valuations. Our 2023-25 EPS are flat even if we have ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO